Having trouble accessing articles? Reset your cache.

Gleevec imatinib regulatory update

The U.K.'s NICE issued a final appraisal determination recommending against the use of 600 or 800 mg/day

Read the full 174 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE